Opinion: Senate, FTC cracking down on pharma patent shenanigans
Why do Americans pay so much more for common medications than people in other countries? Why does an inhaler that costs $7 in France cost almost $500 in the United States? These are just a few of the questions the Senate Judiciary Committee looked to answer in a recent hearing. The common answer? Dominant corporations use a variety of patent-related strategies to protect their power, maximize their profits, and squash their competition.
Americans are facing an affordability crisis at the hands of corporate titans. One in three people cannot afford the medications their doctors prescribe. These medications don’t have to be so expensive, but all too often pharmaceutical companies use illegal tactics to block competition that could lower prices and encourage innovation.
Read Original Article: Opinion: Senate, FTC cracking down on pharma patent shenanigans »
